Wagener MM - Search Results

1

Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.

Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N. Osawa R, et al. Among authors: wagener mm. Transplantation. 2010 Jan 15;89(1):69-74. doi: 10.1097/TP.0b013e3181bcda41. Transplantation. 2010. PMID: 20061921 Free PMC article.

2

Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes.

Wagener MM, Yu VL. Wagener MM, et al. Am J Infect Control. 1992 Oct;20(5):239-47. doi: 10.1016/s0196-6553(05)80197-x. Am J Infect Control. 1992. PMID: 1443756

3

Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants.

Singh N, Gayowski T, Wagener M, Yu VL. Singh N, et al. Transplantation. 1994 Oct 15;58(7):774-8. Transplantation. 1994. PMID: 7524204

4

Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center.

Goetz AM, Ndimbie OK, Wagener MM, Muder RR. Goetz AM, et al. Among authors: wagener mm. Transplantation. 1995 Apr 15;59(7):990-4. doi: 10.1097/00007890-199504150-00012. Transplantation. 1995. PMID: 7535961

5

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.

Singh N, Gayowski T, Yu VL, Wagener MM. Singh N, et al. Among authors: wagener mm. Ann Intern Med. 1995 Apr 15;122(8):595-8. doi: 10.7326/0003-4819-122-8-199504150-00007. Ann Intern Med. 1995. PMID: 7887554 Clinical Trial.

6

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial.

Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. Singh N, et al. Among authors: wagener mm. Ann Intern Med. 1994 Mar 1;120(5):375-81. doi: 10.7326/0003-4819-120-5-199403010-00004. Ann Intern Med. 1994. PMID: 8304654 Clinical Trial.

7

Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease.

Singh N, Yu VL, Mieles LA, Wagener MM. Singh N, et al. Among authors: wagener mm. Am J Med. 1993 Mar;94(3):251-6. doi: 10.1016/0002-9343(93)90056-u. Am J Med. 1993. PMID: 8452148

8

Determinants of nontraditional therapy use in patients with HIV infection. A prospective study.

Singh N, Squier C, Sivek C, Nguyen MH, Wagener M, Yu VL. Singh N, et al. Arch Intern Med. 1996 Jan 22;156(2):197-201. Arch Intern Med. 1996. PMID: 8546553

9

Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies.

Singh N, Gayowski T, Wagener M, Marino IR, Yu VL. Singh N, et al. Transplantation. 1996 Feb 15;61(3):396-401. doi: 10.1097/00007890-199602150-00013. Transplantation. 1996. PMID: 8610349

10

Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis.

Singh N, Gayowski T, Wagener MM, Marino IR. Singh N, et al. Among authors: wagener mm. Transplantation. 1996 Feb 15;61(3):402-6. doi: 10.1097/00007890-199602150-00014. Transplantation. 1996. PMID: 8610350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page